Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
CohBar Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
CohBar Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
CohBar Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
CohBar Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
CohBar Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
CohBar Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
CohBar Raises USD0.5 Million in Venture Financing 11
Licensing Agreements 12
CohBar Enters Into Licensing Agreement With Regents Of The University Of California 12
Equity Offering 14
CohBar Raises USD20 Million in Public Offering of Shares 14
CohBar Plans to Raise up to USD100 Million in Public Offering of Securities 15
CohBar Plans to Raise up to USD18.7 Million in Private Placement of Shares 16
CohBar Raises USD5.2 Million in Private Placement of Units 17
CohBar Raises USD5.3 Million in Private Placement of Shares upon Exercise of Warrants 18
CohBar Raises USD11 Million in IPO of Units 19
CohBar Raises USD2.7 Million in Private Placement of Units 20
CohBar Raises USD2.7 Million in Private Placement of Series B Preferred Stock 21
CohBar Raises USD1.8 Million in Private Placement of Series A Preferred Stock 22
Debt Offering 23
CohBar Raises USD1.8 Million in Second and Final Tranche of Private Placement of Promissory Notes 23
CohBar Raises USD2.14 Million in First Tranche of Private Placement of Promissory Notes 24
CohBar Raises USD0.07 Million in Private Placement of Convertibles Notes 25
CohBar Inc – Key Competitors 26
CohBar Inc – Key Employees 27
CohBar Inc – Locations And Subsidiaries 28
Head Office 28
Recent Developments 29
Financial Announcements 29
Aug 14, 2018: CohBar announces second quarter 2018 financial results 29
May 15, 2018: CohBar Reports First Quarter 2018 Financial Results 31
Apr 02, 2018: CohBar Announces Fourth Quarter 2017 Financial Results 32
Nov 13, 2017: CohBar Announces Third Quarter 2017 Financial Results 34
Aug 14, 2017: CohBar Announces Second Quarter 2017 Financial Results 36
May 15, 2017: CohBar Announces First Quarter 2017 Financial Results 37
Mar 22, 2017: CohBar Announces Fourth Quarter 2016 Financial Results 39
Corporate Communications 40
Jun 07, 2018: CohBar Announces the Appointment of Dr. Philippe Calais to its Board 40
Dec 13, 2017: CohBar Announces Approval for Listing on the NASDAQ Capital MarketNASDAQ Trading to Begin on December 15, 2017 Under Existing Ticker Symbol CWBR 41
Dec 07, 2017: CohBar Announces the Appointment of Dr. John Amatruda to its Board 42
Product News 43
05/29/2018: CohBar to Present CB4211 Novel Mechanism of Action at American Diabetes Association 78th Scientific Sessions 43
Clinical Trials 44
Jun 25, 2018: CohBar Presents Preclinical Data on Mechanism of Action for its Lead Candidate, CB4211, at American Diabetes Association 78th Scientific Sessions 44
Oct 23, 2017: CohBar Presents Preclinical Data on CB4211 Program for NASH at the AASLD Liver Meeting 2017 45
Oct 04, 2017: CohBar Announces Scientific Presentation on Preclinical data of drug candidate CB-4211 for NASH Study at the AASLD Liver Meeting 2017 46
Feb 21, 2017: CohBar Announces Positive Results from Preclinical NASH Study of CB-4211 47
Other Significant Developments 48
Sep 25, 2018: CohBar engages LifeSci advisors as investor relations partner 48
Jun 27, 2018: CohBar Added to Russell 2000 Index 49
Appendix 50
Methodology 50
About GlobalData 50
Contact Us 50
Disclaimer 50
CohBar Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
CohBar Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
CohBar Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
CohBar Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
CohBar Inc, Deals By Therapy Area, 2012 to YTD 2018 9
CohBar Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
CohBar Raises USD0.5 Million in Venture Financing 11
CohBar Enters Into Licensing Agreement With Regents Of The University Of California 12
CohBar Raises USD20 Million in Public Offering of Shares 14
CohBar Plans to Raise up to USD100 Million in Public Offering of Securities 15
CohBar Plans to Raise up to USD18.7 Million in Private Placement of Shares 16
CohBar Raises USD5.2 Million in Private Placement of Units 17
CohBar Raises USD5.3 Million in Private Placement of Shares upon Exercise of Warrants 18
CohBar Raises USD11 Million in IPO of Units 19
CohBar Raises USD2.7 Million in Private Placement of Units 20
CohBar Raises USD2.7 Million in Private Placement of Series B Preferred Stock 21
CohBar Raises USD1.8 Million in Private Placement of Series A Preferred Stock 22
CohBar Raises USD1.8 Million in Second and Final Tranche of Private Placement of Promissory Notes 23
CohBar Raises USD2.14 Million in First Tranche of Private Placement of Promissory Notes 24
CohBar Raises USD0.07 Million in Private Placement of Convertibles Notes 25
CohBar Inc, Key Competitors 26
CohBar Inc, Key Employees 27
List of Figures
CohBar Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
CohBar Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
CohBar Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
CohBar Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
CohBar Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
CohBar Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
CohBar Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
CohBar Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9